JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 35 No. 2 239-244
© 1994 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Houston, A. S.
Right arrow Articles by Macleod, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Houston, A. S.
Right arrow Articles by Macleod, M. A.

A Method for Assessing the Significance of Abnormalities in HMPAO Brain SPECT Images

Alexander S. Houston, Paul M. Kemp and Murdo A. Macleod

Department of Nuclear Medicine, Royal Naval Hospital, Haslar, Gosport, United Kingdom

Correspondence: For correspondence or reprints contact: Dr. A. S. Houston, Dept. of Nuclear Medicine, Royal Naval Hospital, Haslar, Gosport, Hampshire, PO12 2AA, United Kingdom.

ABSTRACT

Methods: A normal atlas for HMPAO rCBF SPECT images was obtained from images of 53 normal controls. Following image registration and normalization, a mean image was extracted, while images representing correlated normal deviants were identified using principal component analysis. These images formed the "building blocks" of the atlas. For subsequent images, the atlas was used to create a "nearest normal equivalent" image, which was compared to a residual standard deviation image to determine the significance of deviations in the new image. Results: Images from 30 patients (10 with Alzheimer's disease;12 with single or multiple infarcts; and 8 normals) were analyzed. Conclusion: Using an optimal decision level, 10/10 patients with Alzheimer's disease and 11/12 patients with infarcts were correctly identified, with only one false-positive resulting. We utilized a database of images obtained from normal controls to create a normal atlas.

Key Words: HMPAO brain SPECT • Alzheimer's disease







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1994 by the Society of Nuclear Medicine.